Building better brain models for Parkinson’s disease and beyond
Drug Target Review
MARCH 3, 2025
Turning this tide, Professor Jens Christian Schwamborn, a cell biology expert at the University of Luxembourg and co-founder of OrganoTherapeutics , is leading a groundbreaking effort to transform our understanding and treatment of these debilitating diseases.
Let's personalize your content